- Home
- CBAN vs AQST Comparison
CBAN vs AQST Comparison
Compare CBAN & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBAN
- AQST
- Stock Information
- Founded
- CBAN 1975
- AQST 2004
- Country
- CBAN United States
- AQST United States
- Employees
- CBAN N/A
- AQST N/A
- Industry
- CBAN Major Banks
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- CBAN Finance
- AQST Health Care
- Exchange
- CBAN Nasdaq
- AQST Nasdaq
- Market Cap
- CBAN 287.3M
- AQST 272.9M
- IPO Year
- CBAN 1998
- AQST 2018
- Fundamental
- Price
- CBAN $17.45
- AQST $4.07
- Analyst Decision
- CBAN
- AQST Strong Buy
- Analyst Count
- CBAN 0
- AQST 7
- Target Price
- CBAN N/A
- AQST $11.29
- AVG Volume (30 Days)
- CBAN 59.6K
- AQST 1.3M
- Earning Date
- CBAN 07-23-2025
- AQST 08-05-2025
- Dividend Yield
- CBAN 2.64%
- AQST N/A
- EPS Growth
- CBAN 14.66
- AQST N/A
- EPS
- CBAN 1.43
- AQST N/A
- Revenue
- CBAN $113,756,000.00
- AQST $54,228,000.00
- Revenue This Year
- CBAN $18.25
- AQST N/A
- Revenue Next Year
- CBAN $7.59
- AQST $45.71
- P/E Ratio
- CBAN $12.17
- AQST N/A
- Revenue Growth
- CBAN 3.33
- AQST 5.29
- 52 Week Low
- CBAN $12.65
- AQST $2.12
- 52 Week High
- CBAN $18.49
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- CBAN 73.26
- AQST 72.86
- Support Level
- CBAN $17.26
- AQST $3.62
- Resistance Level
- CBAN $18.01
- AQST $3.80
- Average True Range (ATR)
- CBAN 0.39
- AQST 0.19
- MACD
- CBAN 0.19
- AQST 0.05
- Stochastic Oscillator
- CBAN 97.17
- AQST 95.43
About CBAN Colony Bankcorp Inc.
Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.